# Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.

> **NCT01467518** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 11 (actual)

## Conditions studied

- Infections, Human Immunodeficiency Virus and Hepatitis

## Interventions

- **DRUG:** Dolutegravir
- **DRUG:** Methadone

## Key facts

- **NCT ID:** NCT01467518
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2012-04-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01467518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01467518, "Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01467518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*